Monopar Therapeutics
- Stock
- Ticker MNPR
- ISIN US61023L2079
- Nasdaq
Performance, volatility and drawdowns of Monopar Therapeutics since 12/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $28,750. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.9% in 11/2023, measured from the peak in 12/2019. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | – | – | – | – | – | 0.0 | 0.0 | 0.0 |
| Operating income | -11 | -3.2 | -3.2 | -4.1 | -6.2 | -5.2 | -6.6 | -7.5 |
| Net income | -11 | -2.6 | -2.5 | -3.4 | -5.2 | -3.9 | -5.3 | -6.2 |
| Earnings per share | -2.75 | -0.38 | -0.35 | -0.48 | -0.64 | -0.46 | -0.62 | -0.72 |
| Balance sheet | ||||||||
| Total assets | 60 | 55 | 54 | 144 | 141 | 138 | 135 | 130 |
| Liabilities | 5.3 | 1.5 | 1.7 | 2.6 | 2.9 | 2.6 | 4.1 | 3.2 |
| Equity | 55 | 54 | 52 | 142 | 138 | 135 | 131 | 127 |
| Cash | 46 | 40 | 40 | 128 | 62 | 53 | 53 | 53 |
| Cash flow | ||||||||
| Operating cash flow | -2.0 | -5.7 | -1.1 | -2.4 | -3.1 | -3.5 | -3.2 | -6.2 |
| Free cash flow | -2.0 | -5.7 | -1.1 | -2.4 | -3.1 | -3.5 | -3.2 | -6.2 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +1,193.4%, weakest 2023 at −85.6%. 2 of 6 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 12 Nov 2026 | −$0.72 |
| 12 Aug 2026 | −$0.62 |
| 14 May 2026 | −$0.46 |
| 27 Mar 2026 | −$0.64 |
| 13 Nov 2025 | −$0.48 |
| 12 Aug 2025 | −$0.35 |
| 13 May 2025 | −$0.38 |
| 31 Mar 2025 | −$2.75 |
| 8 Nov 2024 | −$0.37 |
| 9 Aug 2024 | −$0.49 |
| 9 May 2024 | −$0.51 |
| 28 Mar 2024 | −$0.61 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €424m
- Market cap in trading currency
- $468m
- Enterprise value
- $362m
- P/E
- –
- P/S
- –
- P/B
- 3.68
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -3.4%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- –
- Net income
- −$20.6m
- Earnings per share
- −$2.44
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -15.3%
- Return on assets
- -15.8%
Balance sheet and cash flow
- Cash
- $105m
- Cash per share
- $15.51
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 43.55
- Book value per share
- $18.75
- Operating cash flow
- −$16.0m
- Free cash flow
- −$16.0m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 6.78m
- Volume
- 132,505
- Avg. volume 3 months
- 158,591
- Relative volume
- 0.9
Price and technicals
- Price
- $69.00
- 1 day
- −1.8%
- 52-week high
- $123.84
- 52-week low
- $50.12
- Distance to 52-week high
- −44.3%
- Distance to 52-week low
- +37.7%
- Distance to 50-day line
- −11.9%
- Distance to 200-day line
- −11.0%
- RSI (14)
- 40
- Volatility 1M
- 53.8%
Performance
- 1 week
- −4.2%
- 1 month
- −4.9%
- 3 months
- −38.0%
- 6 months
- +9.3%
- YTD
- +5.7%
- 1 year
- −16.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has MNPR performed since 12/2019?
$10,000 grew to $5,208 by 20 Nov 2026, which is −9.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is MNPR?
Volatility was 136.6% per year, measured on monthly returns. The largest decline from a peak was −98.9%, with the low in 11/2023.
How does MNPR compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.6% per year at 16.6% volatility, MNPR returned −9.0% at 136.6%. The correlation of monthly returns was 0.16; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.